Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ·Healthcare·Biotechnology
$15.85
-0.03%
Mkt Cap $2.01B
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$15.50
Range $15.00 – $16.00
Implied Upside
-2.2%
Consensus $15.50 vs current $15.85
NASDAQ·Healthcare·Biotechnology
$15.85
-0.03%
Mkt Cap $2.01B
No recent rating data.
Price Target (9 analysts)
$15.50
Range $15.00 – $16.00
-2.2%
Consensus $15.50 vs current $15.85